Cargando…
Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS?
BACKGROUND: Sepsis may be accompanied by acute respiratory distress syndrome (ARDS) in patients admitted to intensive care units (ICUs). It is essential to identify prognostic biomarkers in patients with sepsis and ARDS. OBJECTIVE: Determine whether changes in the level of serum fibroblast growth fa...
Autores principales: | Li, Xing, Shen, Hua, Zhou, Tinghong, Cao, Xiaoyu, Chen, Ying, Liang, Yan, Lu, Ting, He, Jiafen, Dou, Zhoulin, Liu, Chuankai, Tang, Yong, Zhu, Zexiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216835/ https://www.ncbi.nlm.nih.gov/pubmed/34154595 http://dx.doi.org/10.1186/s12931-021-01778-w |
Ejemplares similares
-
Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis
por: Li, Xing, et al.
Publicado: (2021) -
The predictive value of microRNA‐21 for sepsis risk and its correlation with disease severity, systemic inflammation, and 28‐day mortality in sepsis patients
por: Na, Lei, et al.
Publicado: (2019) -
High 28-day mortality in critically ill patients with sepsis and concomitant active cancer
por: Wang, Yong-gang, et al.
Publicado: (2018) -
Increased FGF21 plasma levels in humans with sepsis and SIRS
por: Gariani, Karim, et al.
Publicado: (2013) -
Atrial fibrillation is not an independent determinant of 28-day mortality among critically III sepsis patients
por: Wang, Weiping, et al.
Publicado: (2023)